ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,825
-0,96%
Bitcoin
62 529,42
5,76%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vaccinex Inc (VCNX)

  7. Vaccinex Inc (VCNX) Actualités

VCNX Vaccinex Inc

6,05
-0,13 (-2,10%)
Après les heures de négociation
Dernière mise à jour : 22:07:22
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vaccinex Inc VCNX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,13 -2,10% 6,05 22:07:22
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,01 6,01 6,59 6,05 6,18
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202414:30GLOBEVaccinex Reports 2023 Financial Results and Provides..
27/3/202413:30GLOBEVaccinex, Inc. Announces $1.5 Million Registered Direct..
04/3/202422:19EDGAR2Form 8-K - Current report
21/2/202416:10EDGAR2Form 8-K - Current report
21/2/202414:00GLOBEVaccinex Announces Multiple New Agreements for Access to..
15/2/202414:06EDGAR2Form 8-K - Current report
15/2/202414:00GLOBEVaccinex, Inc. Announces Reverse Stock Split
13/2/202422:30EDGAR2Form 8-K - Current report
13/2/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
12/2/202422:22EDGAR2Form SC 13D/A - General statement of acquisition of..
09/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/2/202414:20EDGAR2Form 8-K/A - Current report: [Amend]
07/2/202421:43EDGAR2Form 8-K - Current report
07/2/202414:00GLOBEVaccinex Announces Pricing of $3.7 Million PIPE Financing
22/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/1/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
08/1/202422:16EDGAR2Form DEF 14A - Other definitive proxy statements
28/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:15EDGAR2Form PRE 14A - Other preliminary proxy statements
12/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBENasdaq Grants Vaccinex Extension Until March 4, 2024 to..
13/11/202314:00GLOBEVaccinex Reports Third Quarter 2023 Financial Results and..
13/11/202313:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202314:00GLOBEVaccinex Reports Clinical Benefit in Interim Analyses from..
26/10/202315:30EDGAR2Form 8-K - Current report
26/10/202315:30GLOBEVaccinex Reports Positive Effect of Pepinemab Treatment on..
25/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202322:54EDGAR2Form 8-K - Current report
12/10/202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
05/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:20EDGAR2Form 8-K - Current report
02/10/202315:16EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/9/202302:41EDGAR2Form S-1MEF - Registration adding securities to prior Form..
27/9/202314:00EDGAR2Form 8-K - Current report
26/9/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
26/9/202314:06EDGAR2Form 8-K - Current report
26/9/202314:01EDGAR2Form S-1/A - General form for registration of securities..
25/9/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202322:37EDGAR2Form 8-K - Current report
22/9/202322:21EDGAR2Form 8-K - Current report
14/9/202323:26EDGAR2Form S-1 - General form for registration of securities under..
13/9/202312:46EDGAR2Form 8-K - Current report
22/8/202322:31EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
VCNX
Vaccinex
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés